136 related articles for article (PubMed ID: 2205949)
1. The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems.
Elgue G; Pasche B; Blombäck M; Olsson P
Thromb Haemost; 1990 Jun; 63(3):435-8. PubMed ID: 2205949
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
[TBL] [Abstract][Full Text] [Related]
3. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
Pelzer H; Schwarz A; Heimburger N
Thromb Haemost; 1988 Feb; 59(1):101-6. PubMed ID: 3363526
[TBL] [Abstract][Full Text] [Related]
4. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
Heimburger N; Pelzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):269-73. PubMed ID: 2465214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
6. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
Meyer D; Tsakiris DA; Marbet GA
Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
Römisch J; Pâques EP
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
10. A microtitre plate ELISA to measure thrombin-antithrombin complex using pan-specific antibodies.
Boisclair MD; Lane DA
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):795-802. PubMed ID: 1489901
[TBL] [Abstract][Full Text] [Related]
11. [Thrombin/antithrombin III complex (TAT)--a new parameter for detection of thrombotic states].
Pelzer H
Rinsho Byori; 1989 Apr; Spec No 81():198-201. PubMed ID: 2666687
[No Abstract] [Full Text] [Related]
12. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].
Guidi L; Bartoloni C; Pellicanò P; Cappelli A; Cursi F; Pili R; Tricerri A; Patriarca F; Gambassi G
Clin Ter; 1991 Mar; 136(6):367-73. PubMed ID: 1828201
[TBL] [Abstract][Full Text] [Related]
13. Determination of thrombin-hirudin complex in plasma with an enzyme-linked immunosorbent assay.
Bichler J; Siebeck M; Maschler R; Pelzer H; Fritz H
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):129-33. PubMed ID: 1772980
[TBL] [Abstract][Full Text] [Related]
14. [The thrombin-antithrombin III complex ELISA test in diagnosis of surgery-induced blood coagulation activation].
Kemen M; Sperling H; Mumme A; Zumtobel V
Infusionstherapie; 1991 Aug; 18(4):199-201. PubMed ID: 1937844
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
16. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
17. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
[TBL] [Abstract][Full Text] [Related]
18. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
Malukiewicz-Wiśniewska G; Kotschy M
Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
[TBL] [Abstract][Full Text] [Related]
19. [Importance of the determination of thrombin-antithrombin-III complexes in hypercoagulability states].
García Avello A; García Frade A; Sureda JL; Torrado MC
Sangre (Barc); 1991 Apr; 36(2):163. PubMed ID: 1866654
[No Abstract] [Full Text] [Related]
20. [Thrombin markers in pregnant women: measurements of prothrombin fragments F 1+2 and thrombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid].
Uszyński W; Uszyński M; Zekanowska E
Ginekol Pol; 2004 Aug; 75(8):595-602. PubMed ID: 15517782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
